西亚试剂：A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cy

发布时间：2025-07-06

In normal cells, p53 is activated by DNA damage checkpoint kinases to simultaneously control the G1/S and G2/M cell cycle checkpoints through transcriptional induction of p21cip1 and Gadd45α. In p53-mutant tumors, cell cycle checkpoints are rewired, leading to dependency on the p38/MK2 pathway to survive DNA-damaging chemotherapy. Here we show that the RNA binding protein hnRNPA0 is the “successor” to p53 for checkpoint control. Like p53, hnRNPA0 is activated by a checkpoint kinase (MK2) and simultaneously controls both cell cycle checkpoints through distinct target mRNAs, but unlike p53, this is through the post-transcriptional stabilization of p27Kip1 and Gadd45α mRNAs. This pathway drives cisplatin resistance in lung cancer, demonstrating the importance of post-transcriptional RNA control to chemotherapy response.

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供

上一篇：西亚试剂 ：间二甲苯-4-磺酸
下一篇：西亚试剂：2-C-支链寡糖及其衍生物的立体选择性合成取得新进展